{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:18:06Z","timestamp":1762017486311},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.neuropharm.2011.03.006","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T08:16:52Z","timestamp":1300263412000},"page":"87-94","source":"Crossref","is-referenced-by-count":13,"title":["Alterations in striatal oxidative stress level produced by pharmacological manipulation of dopamine as shown by a novel synthetic marker molecule"],"prefix":"10.1016","volume":"61","author":[{"given":"Y.","family":"Aluf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.M.","family":"Finberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.03.006_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0091-3057(01)00574-3","article-title":"Effects of amphetamine and sydnocarb on dopamine release and free radical generation in rat striatum","volume":"69","author":"Afanas\u2019ev","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0278-5846(02)00340-8","article-title":"Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione\/reduced glutathione ratio (GSSG\/GSH) enhancement in rats","volume":"27","author":"Abilio","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.03.006_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/10715761003692529","article-title":"Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule","volume":"44","author":"Aluf","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03033137","article-title":"Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease","volume":"5","author":"Asanuma","year":"2003","journal-title":"Neurotox Res."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01249085","article-title":"Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromine","volume":"65","author":"Baker","year":"1986","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF03033567","article-title":"Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms","volume":"11","author":"Cadet","year":"2007","journal-title":"Neurotox Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2011.03.006_bib7","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/mds.22801","article-title":"A\u00a0molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson\u2019s disease","volume":"25","author":"Chan","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib8","first-page":"251","article-title":"Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism","volume":"60","author":"Chiueh","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib9","doi-asserted-by":"crossref","first-page":"27850","DOI":"10.1074\/jbc.M110.101196","article-title":"Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin\/peroxiredoxin system","volume":"285","author":"Drechsel","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.410320616","article-title":"The oxidant stress hypothesis in Parkinson\u2019s disease: evidence supporting it","volume":"32","author":"Fahn","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s007020200021","article-title":"Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO)","volume":"109","author":"Fitzgerald","year":"2002","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib12","first-page":"241","article-title":"Oxidative stress: a role in the pathogenesis of Parkinson\u2019s disease","volume":"29","author":"Gotz","year":"1990","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib13","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/S0024-3205(97)00924-7","article-title":"Amphetamine induces hydroxyl radical formation in the striatum of rats","volume":"61","author":"Huang","year":"1997","journal-title":"Life Sci."},{"issue":"Suppl. 3","key":"10.1016\/j.neuropharm.2011.03.006_bib14","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson\u2019s disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib15","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.66.10_suppl_4.S24","article-title":"The pathogenesis of cell death in Parkinson\u2019s disease","volume":"66","author":"Jenner","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2011.03.006_bib16","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1046\/j.1471-4159.2000.0742296.x","article-title":"Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells","volume":"74","author":"Jones","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib17","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/j.bmc.2007.03.052","article-title":"An exogenous marker: a novel approach for the characterization of oxidative stress","volume":"15","author":"Khatib","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0736-5748(00)00022-8","article-title":"Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB\/c mice","volume":"18","author":"Kita","year":"2000","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(02)01913-1","article-title":"Hydrogen peroxide production by monoamine oxidase during ischemia\/reperfusion","volume":"448","author":"Kunduzova","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib20","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1046\/j.1471-4159.1996.67041532.x","article-title":"Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo","volume":"67","author":"Lamensdorf","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/pr.59.2.1","article-title":"Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase","volume":"59","author":"Marchitti","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jnr.490260405","article-title":"Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture","volume":"26","author":"Michel","year":"1990","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib23","first-page":"583","article-title":"Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study","volume":"57","author":"Nowak","year":"2006","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/exnr.1996.0136","article-title":"Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson\u2019s disease","volume":"141","author":"Offen","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib25","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A\u00a0double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/PL00005371","article-title":"Reactive oxygen species production by monoamine oxidases in intact cells","volume":"359","author":"Pizzinat","year":"1999","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2004.03.036","article-title":"The biogenic trace amine tyramine induces a pronounced hydroxyl radical production via a monoamine oxidase dependent mechanism: an in vivo microdialysis study in mouse striatum","volume":"1012","author":"Schmidt","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib29","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.86.4.1398","article-title":"Dopamine turnover and glutathione oxidation: implications for Parkinson disease","volume":"86","author":"Spina","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.03.006_bib30","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1080\/10715760310001616023","article-title":"Cholesterol, linoleic acid or\/and tyrosine yield different spectra of products when oxidized alone or in a mixture: studies in various oxidative systems","volume":"37","author":"Szuchman","year":"2003","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10715760500358787","article-title":"Exogenous N-linoleoyl tyrosine marker as a tool for the characterization of cellular oxidative stress in macrophages","volume":"40","author":"Szuchman","year":"2006","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/13547500701614556","article-title":"Characterization of oxidative stress in blood from diabetic vs. hypercholesterolaemic patients, using a novel synthesized marker","volume":"13","author":"Szuchman","year":"2008","journal-title":"Biomarkers"},{"key":"10.1016\/j.neuropharm.2011.03.006_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.freeradbiomed.2008.11.019","article-title":"Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects","volume":"46","author":"Tavori","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.pbb.2007.10.004","article-title":"Influence of chronic exercise on reserpine-induced oxidative stress in rats: behavioral and antioxidant evaluations","volume":"88","author":"Teixeira","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib35","doi-asserted-by":"crossref","DOI":"10.1089\/scd.2009.0353","article-title":"Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependant apoptosis","author":"Trouche","year":"2010","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2009.05141.x","article-title":"Amphetamine toxicities: classical and emerging mechanisms","volume":"1187","author":"Yamamoto","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-2952(91)90471-G","article-title":"New directions in monoamine oxidase A and B selective inhibitors and substrates","volume":"41","author":"Youdim","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.03.006_bib38","first-page":"217","article-title":"Partial damage to nigrostriatal bundle: compensatory changes and the action of L-dopa","volume":"29","author":"Zigmond","year":"1990","journal-title":"J.\u00a0Neural Transm. Suppl."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811001158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811001158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T01:28:01Z","timestamp":1543886881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811001158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0028390811001158"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.03.006","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}